0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasmid DNA CDMO Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-1K9883
Home | Market Reports | Science| Biological Sciences
Global Plasmid DNA CDMO Market Research Report 2022
BUY CHAPTERS

Global Plasmid DNA CDMO Market Research Report 2025

Code: QYRE-Auto-1K9883
Report
February 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plasmid DNA CDMO Market Size

The global market for Plasmid DNA CDMO was valued at US$ 241 million in the year 2024 and is projected to reach a revised size of US$ 953 million by 2031, growing at a CAGR of 22.0% during the forecast period.

Plasmid DNA CDMO Market

Plasmid DNA CDMO Market

North American market for Plasmid DNA CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Plasmid DNA CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Plasmid DNA CDMO in DNA Vaccines is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Plasmid DNA CDMO include GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics, Cobra Biologics, Obiosh, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid DNA CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid DNA CDMO.
The Plasmid DNA CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasmid DNA CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid DNA CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Plasmid DNA CDMO Market Report

Report Metric Details
Report Name Plasmid DNA CDMO Market
Accounted market size in year US$ 241 million
Forecasted market size in 2031 US$ 953 million
CAGR 22.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • GMP Grade Plasmid DNA
  • Non-GMP Grade Plasmid DNA
Segment by Application
  • DNA Vaccines
  • Gene Therapy
  • Immunotherapy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics, Cobra Biologics, Obiosh, Thermo Fisher, Aldevron(Danaher), Charles River Laboratories, WuXi AppTec, AGC Biologics, AcuraBio, GENE Chem, Eurogentec, PlasmidFactory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Plasmid DNA CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Plasmid DNA CDMO Market growing?

Ans: The Plasmid DNA CDMO Market witnessing a CAGR of 22.0% during the forecast period 2025-2031.

What is the Plasmid DNA CDMO Market size in 2031?

Ans: The Plasmid DNA CDMO Market size in 2031 will be US$ 953 million.

Who are the main players in the Plasmid DNA CDMO Market report?

Ans: The main players in the Plasmid DNA CDMO Market are GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Catalent, Richter-Helm BioLogics, Cytovance Biologics, Cobra Biologics, Obiosh, Thermo Fisher, Aldevron(Danaher), Charles River Laboratories, WuXi AppTec, AGC Biologics, AcuraBio, GENE Chem, Eurogentec, PlasmidFactory

What are the Application segmentation covered in the Plasmid DNA CDMO Market report?

Ans: The Applications covered in the Plasmid DNA CDMO Market report are DNA Vaccines, Gene Therapy, Immunotherapy, Others

What are the Type segmentation covered in the Plasmid DNA CDMO Market report?

Ans: The Types covered in the Plasmid DNA CDMO Market report are GMP Grade Plasmid DNA, Non-GMP Grade Plasmid DNA

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA CDMO Market Perspective (2020-2031)
2.2 Global Plasmid DNA CDMO Growth Trends by Region
2.2.1 Global Plasmid DNA CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plasmid DNA CDMO Historic Market Size by Region (2020-2025)
2.2.3 Plasmid DNA CDMO Forecasted Market Size by Region (2026-2031)
2.3 Plasmid DNA CDMO Market Dynamics
2.3.1 Plasmid DNA CDMO Industry Trends
2.3.2 Plasmid DNA CDMO Market Drivers
2.3.3 Plasmid DNA CDMO Market Challenges
2.3.4 Plasmid DNA CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA CDMO Players by Revenue
3.1.1 Global Top Plasmid DNA CDMO Players by Revenue (2020-2025)
3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasmid DNA CDMO Revenue
3.4 Global Plasmid DNA CDMO Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Revenue in 2024
3.5 Global Key Players of Plasmid DNA CDMO Head office and Area Served
3.6 Global Key Players of Plasmid DNA CDMO, Product and Application
3.7 Global Key Players of Plasmid DNA CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA CDMO Breakdown Data by Type
4.1 Global Plasmid DNA CDMO Historic Market Size by Type (2020-2025)
4.2 Global Plasmid DNA CDMO Forecasted Market Size by Type (2026-2031)
5 Plasmid DNA CDMO Breakdown Data by Application
5.1 Global Plasmid DNA CDMO Historic Market Size by Application (2020-2025)
5.2 Global Plasmid DNA CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plasmid DNA CDMO Market Size (2020-2031)
6.2 North America Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plasmid DNA CDMO Market Size by Country (2020-2025)
6.4 North America Plasmid DNA CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid DNA CDMO Market Size (2020-2031)
7.2 Europe Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plasmid DNA CDMO Market Size by Country (2020-2025)
7.4 Europe Plasmid DNA CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA CDMO Market Size (2020-2031)
8.2 Asia-Pacific Plasmid DNA CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid DNA CDMO Market Size (2020-2031)
9.2 Latin America Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plasmid DNA CDMO Market Size by Country (2020-2025)
9.4 Latin America Plasmid DNA CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA CDMO Market Size (2020-2031)
10.2 Middle East & Africa Plasmid DNA CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Details
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid DNA CDMO Introduction
11.1.4 GenScript ProBio Revenue in Plasmid DNA CDMO Business (2020-2025)
11.1.5 GenScript ProBio Recent Development
11.2 Biovian
11.2.1 Biovian Company Details
11.2.2 Biovian Business Overview
11.2.3 Biovian Plasmid DNA CDMO Introduction
11.2.4 Biovian Revenue in Plasmid DNA CDMO Business (2020-2025)
11.2.5 Biovian Recent Development
11.3 Biomay
11.3.1 Biomay Company Details
11.3.2 Biomay Business Overview
11.3.3 Biomay Plasmid DNA CDMO Introduction
11.3.4 Biomay Revenue in Plasmid DNA CDMO Business (2020-2025)
11.3.5 Biomay Recent Development
11.4 VGXI
11.4.1 VGXI Company Details
11.4.2 VGXI Business Overview
11.4.3 VGXI Plasmid DNA CDMO Introduction
11.4.4 VGXI Revenue in Plasmid DNA CDMO Business (2020-2025)
11.4.5 VGXI Recent Development
11.5 Esco Aster
11.5.1 Esco Aster Company Details
11.5.2 Esco Aster Business Overview
11.5.3 Esco Aster Plasmid DNA CDMO Introduction
11.5.4 Esco Aster Revenue in Plasmid DNA CDMO Business (2020-2025)
11.5.5 Esco Aster Recent Development
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Plasmid DNA CDMO Introduction
11.6.4 Catalent Revenue in Plasmid DNA CDMO Business (2020-2025)
11.6.5 Catalent Recent Development
11.7 Richter-Helm BioLogics
11.7.1 Richter-Helm BioLogics Company Details
11.7.2 Richter-Helm BioLogics Business Overview
11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Introduction
11.7.4 Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.7.5 Richter-Helm BioLogics Recent Development
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Details
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Plasmid DNA CDMO Introduction
11.8.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.8.5 Cytovance Biologics Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Plasmid DNA CDMO Introduction
11.9.4 Cobra Biologics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.9.5 Cobra Biologics Recent Development
11.10 Obiosh
11.10.1 Obiosh Company Details
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Plasmid DNA CDMO Introduction
11.10.4 Obiosh Revenue in Plasmid DNA CDMO Business (2020-2025)
11.10.5 Obiosh Recent Development
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Details
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Plasmid DNA CDMO Introduction
11.11.4 Thermo Fisher Revenue in Plasmid DNA CDMO Business (2020-2025)
11.11.5 Thermo Fisher Recent Development
11.12 Aldevron(Danaher)
11.12.1 Aldevron(Danaher) Company Details
11.12.2 Aldevron(Danaher) Business Overview
11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Introduction
11.12.4 Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2020-2025)
11.12.5 Aldevron(Danaher) Recent Development
11.13 Charles River Laboratories
11.13.1 Charles River Laboratories Company Details
11.13.2 Charles River Laboratories Business Overview
11.13.3 Charles River Laboratories Plasmid DNA CDMO Introduction
11.13.4 Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2020-2025)
11.13.5 Charles River Laboratories Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Plasmid DNA CDMO Introduction
11.14.4 WuXi AppTec Revenue in Plasmid DNA CDMO Business (2020-2025)
11.14.5 WuXi AppTec Recent Development
11.15 AGC Biologics
11.15.1 AGC Biologics Company Details
11.15.2 AGC Biologics Business Overview
11.15.3 AGC Biologics Plasmid DNA CDMO Introduction
11.15.4 AGC Biologics Revenue in Plasmid DNA CDMO Business (2020-2025)
11.15.5 AGC Biologics Recent Development
11.16 AcuraBio
11.16.1 AcuraBio Company Details
11.16.2 AcuraBio Business Overview
11.16.3 AcuraBio Plasmid DNA CDMO Introduction
11.16.4 AcuraBio Revenue in Plasmid DNA CDMO Business (2020-2025)
11.16.5 AcuraBio Recent Development
11.17 GENE Chem
11.17.1 GENE Chem Company Details
11.17.2 GENE Chem Business Overview
11.17.3 GENE Chem Plasmid DNA CDMO Introduction
11.17.4 GENE Chem Revenue in Plasmid DNA CDMO Business (2020-2025)
11.17.5 GENE Chem Recent Development
11.18 Eurogentec
11.18.1 Eurogentec Company Details
11.18.2 Eurogentec Business Overview
11.18.3 Eurogentec Plasmid DNA CDMO Introduction
11.18.4 Eurogentec Revenue in Plasmid DNA CDMO Business (2020-2025)
11.18.5 Eurogentec Recent Development
11.19 PlasmidFactory
11.19.1 PlasmidFactory Company Details
11.19.2 PlasmidFactory Business Overview
11.19.3 PlasmidFactory Plasmid DNA CDMO Introduction
11.19.4 PlasmidFactory Revenue in Plasmid DNA CDMO Business (2020-2025)
11.19.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of GMP Grade Plasmid DNA
 Table 3. Key Players of Non-GMP Grade Plasmid DNA
 Table 4. Global Plasmid DNA CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Plasmid DNA CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Plasmid DNA CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Plasmid DNA CDMO Market Share by Region (2020-2025)
 Table 8. Global Plasmid DNA CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Plasmid DNA CDMO Market Share by Region (2026-2031)
 Table 10. Plasmid DNA CDMO Market Trends
 Table 11. Plasmid DNA CDMO Market Drivers
 Table 12. Plasmid DNA CDMO Market Challenges
 Table 13. Plasmid DNA CDMO Market Restraints
 Table 14. Global Plasmid DNA CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Plasmid DNA CDMO Market Share by Players (2020-2025)
 Table 16. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2024)
 Table 17. Ranking of Global Top Plasmid DNA CDMO Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Plasmid DNA CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Plasmid DNA CDMO, Headquarters and Area Served
 Table 20. Global Key Players of Plasmid DNA CDMO, Product and Application
 Table 21. Global Key Players of Plasmid DNA CDMO, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Plasmid DNA CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Plasmid DNA CDMO Revenue Market Share by Type (2020-2025)
 Table 25. Global Plasmid DNA CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Plasmid DNA CDMO Revenue Market Share by Type (2026-2031)
 Table 27. Global Plasmid DNA CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Plasmid DNA CDMO Revenue Market Share by Application (2020-2025)
 Table 29. Global Plasmid DNA CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Plasmid DNA CDMO Revenue Market Share by Application (2026-2031)
 Table 31. North America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Plasmid DNA CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Plasmid DNA CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Plasmid DNA CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Plasmid DNA CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 46. GenScript ProBio Company Details
 Table 47. GenScript ProBio Business Overview
 Table 48. GenScript ProBio Plasmid DNA CDMO Product
 Table 49. GenScript ProBio Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 50. GenScript ProBio Recent Development
 Table 51. Biovian Company Details
 Table 52. Biovian Business Overview
 Table 53. Biovian Plasmid DNA CDMO Product
 Table 54. Biovian Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 55. Biovian Recent Development
 Table 56. Biomay Company Details
 Table 57. Biomay Business Overview
 Table 58. Biomay Plasmid DNA CDMO Product
 Table 59. Biomay Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 60. Biomay Recent Development
 Table 61. VGXI Company Details
 Table 62. VGXI Business Overview
 Table 63. VGXI Plasmid DNA CDMO Product
 Table 64. VGXI Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 65. VGXI Recent Development
 Table 66. Esco Aster Company Details
 Table 67. Esco Aster Business Overview
 Table 68. Esco Aster Plasmid DNA CDMO Product
 Table 69. Esco Aster Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 70. Esco Aster Recent Development
 Table 71. Catalent Company Details
 Table 72. Catalent Business Overview
 Table 73. Catalent Plasmid DNA CDMO Product
 Table 74. Catalent Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 75. Catalent Recent Development
 Table 76. Richter-Helm BioLogics Company Details
 Table 77. Richter-Helm BioLogics Business Overview
 Table 78. Richter-Helm BioLogics Plasmid DNA CDMO Product
 Table 79. Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 80. Richter-Helm BioLogics Recent Development
 Table 81. Cytovance Biologics Company Details
 Table 82. Cytovance Biologics Business Overview
 Table 83. Cytovance Biologics Plasmid DNA CDMO Product
 Table 84. Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 85. Cytovance Biologics Recent Development
 Table 86. Cobra Biologics Company Details
 Table 87. Cobra Biologics Business Overview
 Table 88. Cobra Biologics Plasmid DNA CDMO Product
 Table 89. Cobra Biologics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 90. Cobra Biologics Recent Development
 Table 91. Obiosh Company Details
 Table 92. Obiosh Business Overview
 Table 93. Obiosh Plasmid DNA CDMO Product
 Table 94. Obiosh Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 95. Obiosh Recent Development
 Table 96. Thermo Fisher Company Details
 Table 97. Thermo Fisher Business Overview
 Table 98. Thermo Fisher Plasmid DNA CDMO Product
 Table 99. Thermo Fisher Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 100. Thermo Fisher Recent Development
 Table 101. Aldevron(Danaher) Company Details
 Table 102. Aldevron(Danaher) Business Overview
 Table 103. Aldevron(Danaher) Plasmid DNA CDMO Product
 Table 104. Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 105. Aldevron(Danaher) Recent Development
 Table 106. Charles River Laboratories Company Details
 Table 107. Charles River Laboratories Business Overview
 Table 108. Charles River Laboratories Plasmid DNA CDMO Product
 Table 109. Charles River Laboratories Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 110. Charles River Laboratories Recent Development
 Table 111. WuXi AppTec Company Details
 Table 112. WuXi AppTec Business Overview
 Table 113. WuXi AppTec Plasmid DNA CDMO Product
 Table 114. WuXi AppTec Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 115. WuXi AppTec Recent Development
 Table 116. AGC Biologics Company Details
 Table 117. AGC Biologics Business Overview
 Table 118. AGC Biologics Plasmid DNA CDMO Product
 Table 119. AGC Biologics Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 120. AGC Biologics Recent Development
 Table 121. AcuraBio Company Details
 Table 122. AcuraBio Business Overview
 Table 123. AcuraBio Plasmid DNA CDMO Product
 Table 124. AcuraBio Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 125. AcuraBio Recent Development
 Table 126. GENE Chem Company Details
 Table 127. GENE Chem Business Overview
 Table 128. GENE Chem Plasmid DNA CDMO Product
 Table 129. GENE Chem Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 130. GENE Chem Recent Development
 Table 131. Eurogentec Company Details
 Table 132. Eurogentec Business Overview
 Table 133. Eurogentec Plasmid DNA CDMO Product
 Table 134. Eurogentec Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 135. Eurogentec Recent Development
 Table 136. PlasmidFactory Company Details
 Table 137. PlasmidFactory Business Overview
 Table 138. PlasmidFactory Plasmid DNA CDMO Product
 Table 139. PlasmidFactory Revenue in Plasmid DNA CDMO Business (2020-2025) & (US$ Million)
 Table 140. PlasmidFactory Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Plasmid DNA CDMO Picture
 Figure 2. Global Plasmid DNA CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Plasmid DNA CDMO Market Share by Type: 2024 VS 2031
 Figure 4. GMP Grade Plasmid DNA Features
 Figure 5. Non-GMP Grade Plasmid DNA Features
 Figure 6. Global Plasmid DNA CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Plasmid DNA CDMO Market Share by Application: 2024 VS 2031
 Figure 8. DNA Vaccines Case Studies
 Figure 9. Gene Therapy Case Studies
 Figure 10. Immunotherapy Case Studies
 Figure 11. Others Case Studies
 Figure 12. Plasmid DNA CDMO Report Years Considered
 Figure 13. Global Plasmid DNA CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Plasmid DNA CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Plasmid DNA CDMO Market Share by Region: 2024 VS 2031
 Figure 16. Global Plasmid DNA CDMO Market Share by Players in 2024
 Figure 17. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2024
 Figure 19. North America Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Plasmid DNA CDMO Market Share by Country (2020-2031)
 Figure 21. United States Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Plasmid DNA CDMO Market Share by Country (2020-2031)
 Figure 25. Germany Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Plasmid DNA CDMO Market Share by Region (2020-2031)
 Figure 33. China Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Plasmid DNA CDMO Market Share by Country (2020-2031)
 Figure 41. Mexico Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Plasmid DNA CDMO Market Share by Country (2020-2031)
 Figure 45. Turkey Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Plasmid DNA CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. GenScript ProBio Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 49. Biovian Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 50. Biomay Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 51. VGXI Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 52. Esco Aster Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 53. Catalent Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 54. Richter-Helm BioLogics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 55. Cytovance Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 56. Cobra Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 57. Obiosh Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 58. Thermo Fisher Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 59. Aldevron(Danaher) Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 60. Charles River Laboratories Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 61. WuXi AppTec Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 62. AGC Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 63. AcuraBio Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 64. GENE Chem Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 65. Eurogentec Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 66. PlasmidFactory Revenue Growth Rate in Plasmid DNA CDMO Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS